Protect your wound with the ALLEVYN GENTLE foam dressing. The gentle foam dressing technology promotes optimum wound healing and protects sensitive skin. Ideal for chronic and acute wounds.
€78.80*
Prices incl. VAT plus shipping costs (Kann sich je nach Land ändern)
⁴
Protect your wound with the ALLEVYN GENTLE foam dressing. The gentle foam dressing technology promotes optimum wound healing and protects sensitive skin. Ideal for chronic and acute wounds.
Gently adhering silicone foam dressing for the treatment of wounds with moderate to heavy exudation. The gentle adhesion facilitates secondary fixation - sterile.
ALLEVYN GENTLE dressings are suitable for a wide range of acute and chronic wounds with secondary fixation, even on difficult areas of the body.1,3,6 ALLEVYN GENTLE dressings are designed for reliable everyday use and the challenges of wound treatment on sensitive skin4,5 and can be used for up to 7 days.*6-8
Properties
- Suitable for sensitive skin: The dressings have a gentle silicone contact layer to keep the dressing gently in place during dressing9,10 and minimise pain and trauma to the wound during dressing changes.10,11
- Versatile: A soft dressing that stretches in all directions and can be cut to fit many wound types1-3.
- High absorbency: Hydrocellular foam absorbs large amounts of exudate1,8,12 and can effectively absorb viscous exudate13 and maintains absorbency under pressure**2
- Promotes rapid healing: The triple action technology promotes a moist wound environment, supporting wound healing, granulation and epithelialisation while minimising the risk of maceration.1,7,8,14
Advantages
- Without adhesive edge
- Secondary fixation necessary
- With silicone wound contact layer
- Reduces trauma and pain during dressing changes
- Soft and cosy, can be cut to size
- Dressing stays in place for up to 7 days
- Suitable for sensitive and intact surrounding skin
*Depending on wound exudate **Proven in laboratory tests. 1 Smith+Nephew 2019 Internal report. RD/19/083 v2. 2 Smith+Nephew 2019. Internal report.DS/19/058/R. 3 Smith+Nephew 2019. Internal report. DS/19/198/R Version 2. 4 Carter J. Paper presented at: Wounds UK; 2008; Harrogate, UK. 5 Rafter L, et al. Wounds UK 12(2): 70-78. 2016. 6 Smith+Nephew 2019. Internal report. DS/19/197/R. 7 Smith+Nephew 2019. Internal report. DS/19/191/R. 8 Smith+Nephew 2019. Internal report. DS/19/196/R Version 2. 9 Smith & Nephew 2014. Internal report. VTR/HVT079/ST965. 10 Vowden K et al. Poster presented at EWMA 2011. 11 Hurd, T, et al. Wounds UK 2009. 12 Benbow M. Br J Nurs. 2008;17 (Tissue Viability Supplement)(15):S4 - S16. 13 Smith+Nephew 2019 Internal report. DS/19/054/R.14 Smith+Nephew 2019. Internal report. EO.AWM.PCS263.001.v1.
Dosage form
Foam dressing
| Stück: | 10 |
|---|